Literature DB >> 6726371

Phenoxybenzamine in the treatment of causalgia. Report of 40 cases.

S Y Ghostine, Y G Comair, D M Turner, N F Kassell, C G Azar.   

Abstract

Forty consecutive cases of causalgia treated during a 7-year period are presented. The patients ranged in age between 17 and 55 years, and all patients were males who received their nerve injuries from missile or shrapnel wounds. The greater occipital nerve was involved in two cases, median nerve in 10, sciatic nerve in 12, brachial plexus in seven, cauda equina in five, and multiple nerves in four cases. Each patient was treated with phenoxybenzamine, a postsynaptic alpha 1-blocker and presynaptic alpha 2-blocking agent. The drug was given orally in gradually increasing increments until a maximum daily dose of 40 to 120 mg was reached. Duration of treatment was usually 6 to 8 weeks. Total resolution of pain was achieved in all cases. The follow-up period ranged between 6 months and 6 years. Side effects of phenoxybenzamine were minimal and transient, consisting primarily of mild orthostatic hypotension and ejaculatory problems. We conclude that oral phenoxybenzamine is a simple, safe, and effective treatment of causalgia.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6726371     DOI: 10.3171/jns.1984.60.6.1263

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  13 in total

Review 1.  The role of radiofrequency in the management of complex regional pain syndrome.

Authors:  L Manchikanti
Journal:  Curr Rev Pain       Date:  2000

2.  Complex regional pain syndrome: state of the art update.

Authors:  Patrick Henson; Stephen Bruehl
Journal:  Curr Treat Options Cardiovasc Med       Date:  2010-04

3.  Complex Regional Pain Syndrome.

Authors:  Ok Yung Chung; Stephen P. Bruehl
Journal:  Curr Treat Options Neurol       Date:  2003-11       Impact factor: 3.598

4.  Evaluation of phenoxybenzamine in the CFA model of pain following gene expression studies and connectivity mapping.

Authors:  Meiping Chang; Sarah Smith; Andrew Thorpe; Michael J Barratt; Farzana Karim
Journal:  Mol Pain       Date:  2010-09-16       Impact factor: 3.395

Review 5.  Complex regional pain syndrome: a review of evidence-supported treatment options.

Authors:  E Daniela Hord; Anne Louise Oaklander
Journal:  Curr Pain Headache Rep       Date:  2003-06

6.  [Development and therapy of the pain syndrome of reflex sympathetic dystrophy. Clinical expression, experimental investigations, and new pathophysiological considerations.].

Authors:  H Blumberg
Journal:  Schmerz       Date:  1988-09       Impact factor: 1.107

7.  [Pharmacotherapy of cancer pain. 3. Adjuvant drugs.].

Authors:  N I Cherny; R K Portenoy; M Raber; M Zenz
Journal:  Schmerz       Date:  1995-03       Impact factor: 1.107

8.  Posttraumatic reflex sympathetic dystrophy: Mechanisms and medical management.

Authors:  R B Patt; K Balter
Journal:  J Occup Rehabil       Date:  1991-03

9.  MRI findings of causalgia of the lower extremity following transsphenoidal resection of pituitary tumor.

Authors:  D Ryan Ormond; Augustine L Moscatello; Raj Murali
Journal:  Case Rep Neurol Med       Date:  2012-09-13

10.  Norepinephrine-induced nociception and vasoconstrictor hypersensitivity in rats with chronic post-ischemia pain.

Authors:  Dimitris N Xanthos; Gary J Bennett; Terence J Coderre
Journal:  Pain       Date:  2008-01-14       Impact factor: 7.926

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.